{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:15:59Z","timestamp":1778634959633,"version":"3.51.4"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-0707424"],"award-info":[{"award-number":["DGE-0707424"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["RO1 MH085953"],"award-info":[{"award-number":["RO1 MH085953"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["5T32MH073526-05"],"award-info":[{"award-number":["5T32MH073526-05"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32 T90DA022768"],"award-info":[{"award-number":["T32 T90DA022768"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["50-HD-055784"],"award-info":[{"award-number":["50-HD-055784"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.09.012","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T08:43:55Z","timestamp":1350981835000},"page":"157-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Converging levels of analysis on a genomic hotspot for psychosis: Insights from 22q11.2 Deletion Syndrome"],"prefix":"10.1016","volume":"68","author":[{"given":"Matthew J.","family":"Schreiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria T.","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Jalbrzikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie E.","family":"Bearden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.09.012_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/schbul\/sbl075","article-title":"North American prodrome longitudinal study: a collaborative multisite approach to prodromal schizophrenia research","volume":"33","author":"Addington","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1207\/s15326942dn2803_6","article-title":"Sex differences in cognitive functioning in velocardiofacial syndrome (VCFS)","volume":"28","author":"Antshel","year":"2005","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pscychresns.2005.02.003","article-title":"Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome)","volume":"138","author":"Antshel","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10803-006-0308-6","article-title":"Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion)","volume":"37","author":"Antshel","year":"2007","journal-title":"J.\u00a0Autism Dev. Disord."},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib202","first-page":"333","article-title":"Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome a 3-year follow-up study","volume":"49","author":"Antshel","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.186.2.115","article-title":"Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group","volume":"186","author":"Baker","year":"2005","journal-title":"Br J Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2012.09.012_bib7","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1176\/appi.ajp.160.10.1863","article-title":"Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study","volume":"160","author":"Barnea-Goraly","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cogbrainres.2005.09.013","article-title":"Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome","volume":"25","author":"Barnea-Goraly","year":"2005","journal-title":"Brain Res. Cogn. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/nbm.1940080707","article-title":"Inferring microstructural features and the physiological state of tissues from diffusion-weighted images","volume":"8","author":"Basser","year":"1995","journal-title":"NMR Biomed."},{"issue":"7","key":"10.1016\/j.neuropharm.2012.09.012_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0006-3223(99)00114-6","article-title":"22Q11 deletion syndrome: a genetic subtype of schizophrenia","volume":"46","author":"Bassett","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1076\/jcen.23.4.447.1228","article-title":"The neurocognitive phenotype of the 22q11.2 deletion syndrome: selective deficit in visual-spatial memory","volume":"23","author":"Bearden","year":"2001","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib204","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/13554790490495519","article-title":"Regional brain abnormalities in 22q11.2 deletion syndrome: association with cognitive abilities and behavioral symptoms","volume":"10","author":"Bearden","year":"2004","journal-title":"Neurocase"},{"issue":"1","key":"10.1016\/j.neuropharm.2012.09.012_bib205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/09297040590911239","article-title":"Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome","volume":"11","author":"Bearden","year":"2005","journal-title":"Child Neuropsychol."},{"issue":"8","key":"10.1016\/j.neuropharm.2012.09.012_bib206","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/cercor\/bhl097","article-title":"Mapping cortical thickness in children with 22q11.2 deletions","volume":"17","author":"Bearden","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cercor\/bhn064","article-title":"Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions","volume":"19","author":"Bearden","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/nbm.782","article-title":"The basis of anisotropic water diffusion in the nervous system \u2013 a technical review","volume":"15","author":"Beaulieu","year":"2002","journal-title":"NMR Biomed."},{"issue":"12","key":"10.1016\/j.neuropharm.2012.09.012_bib15","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/mp.2009.84","article-title":"Schizophrenia is associated with an increase in cortical microRNA biogenesis","volume":"15","author":"Beveridge","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2006.02.001","article-title":"Specific cerebellar reductions in children with chromosome 22q11.2 deletion syndrome","volume":"399","author":"Bish","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cercor\/bhp146","article-title":"Nonlinear response of the anterior cingulate and prefrontal cortex in schizophrenia as a function of variable attentional control","volume":"20","author":"Blasi","year":"2010","journal-title":"Cereb. Cortex"},{"issue":"October","key":"10.1016\/j.neuropharm.2012.09.012_bib18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/ajmg.a.33665","article-title":"Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: potential role for dopamine transporter imaging","author":"Booij","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.npp.1301508","article-title":"Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome","volume":"33","author":"Boot","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/syn.20932","article-title":"COMT Val(158) met genotype and striatal D(2\/3) receptor binding in adults with 22q11 deletion syndrome","volume":"65","author":"Boot","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1177\/0269881109104854","article-title":"Striatal D receptor binding in 22q11 deletion syndrome: an [(1)(2)(3)I]IBZM SPECT study","volume":"24","author":"Boot","year":"2010","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2012.09.012_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.12.020","article-title":"Theory of mind impairment in schizophrenia: meta-analysis","volume":"109","author":"Bora","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","article-title":"Gating and habituation of the startle reflex in schizophrenic patients","volume":"49","author":"Braff","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2005.07.008","article-title":"Biosocial pathways to functional outcome in schizophrenia","volume":"80","author":"Brekke","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/schbul\/sbj077","article-title":"Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis","volume":"32","author":"Brewer","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1037\/0021-843X.112.1.38","article-title":"Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia","volume":"112","author":"Byrne","year":"2003","journal-title":"J.\u00a0Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib28","article-title":"Development and regulation of dendritic dendritic spines: what are they? what are they for?","volume":"21","author":"Calabrese","year":"2006","journal-title":"Physiology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib29","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/brain\/awl066","article-title":"Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study","volume":"129","author":"Campbell","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2008.11.101","article-title":"Brain structural differences associated with the behavioural phenotype in children with Williams syndrome","volume":"1258","author":"Campbell","year":"2009","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2012.09.012_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.psychres.2009.06.007","article-title":"Visual scanning of faces in 22q11.2 deletion syndrome: attention to the mouth or the eyes?","volume":"177","author":"Campbell","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11689-011-9082-7","article-title":"Is theory of mind related to social dysfunction and emotional problems in 22q11.2 deletion syndrome (velo-cardio-facial syndrome)?","volume":"3","author":"Campbell","year":"2011","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":"Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archpsyc.55.1.67","article-title":"The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study","volume":"55","author":"Cannon","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib35","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.052023499","article-title":"Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia","volume":"99","author":"Cannon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.schbul.a007037","article-title":"Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions","volume":"29","author":"Cannon","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1086\/515508","article-title":"Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients","volume":"61","author":"Carlson","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/appi.ajp.2010.10081230","article-title":"Association of schizophrenia in 22q11.2 deletion syndrome and gray matter volumetric deficits in the superior temporal gyrus","volume":"168","author":"Chow","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0006-3223(99)00150-X","article-title":"Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia","volume":"46","author":"Chow","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2006.04.007","article-title":"Neurocognitive profile in 22q11 deletion syndrome and schizophrenia","volume":"87","author":"Chow","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-3223(01)01246-X","article-title":"Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome","volume":"51","author":"Chow","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-8993(97)00721-X","article-title":"Proline-induced inhibition of glutamate release in hippocampal area CA1","volume":"769","author":"Cohen","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib44","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuroimage.2010.01.094","article-title":"The effects of gender and catechol O-methyltransferase (COMT) Val108\/158Met polymorphism on emotion regulation in velo-cardio-facial syndrome (22q11.2 deletion syndrome): an fMRI study","volume":"53","author":"Coman","year":"2010","journal-title":"Neuroimage"},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2012.09.012_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000297067","article-title":"Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia","author":"Cornblatt","year":"1992","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2012.09.012_bib46","doi-asserted-by":"crossref","first-page":"e21685","DOI":"10.1371\/journal.pone.0021685","article-title":"Proton magnetic resonance spectroscopy in 22q11 deletion syndrome","volume":"6","author":"da Silva Alves","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.schres.2011.07.017","article-title":"White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia","volume":"132","author":"da Silva Alves","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00187-7","article-title":"Neuropsychological deficits in children associated with increased familial risk for schizophrenia","volume":"67","author":"Davalos","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib49","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0140-6736(03)14297-3","article-title":"Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder","volume":"362","author":"Davis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib50","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.neuropsychologia.2006.05.006","article-title":"Hippocampal volume reduction in 22q11.2 deletion syndrome","volume":"44","author":"Debbane","year":"2006","journal-title":"Neuropsychologia"},{"issue":"12","key":"10.1016\/j.neuropharm.2012.09.012_bib51","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.biopsych.2011.02.036","article-title":"The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder","volume":"69","author":"Del Campo","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2012.09.012_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/brain\/118.1.279","article-title":"Contributions of anterior cingulate cortex to behaviour","volume":"118","author":"Devinsky","year":"1995","journal-title":"Brain"},{"issue":"220\u2013226","key":"10.1016\/j.neuropharm.2012.09.012_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.mp.4000380","article-title":"Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders","volume":"3","author":"Drevets","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijdevneu.2010.09.007","article-title":"The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders","volume":"29","author":"Drew","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib56","first-page":"2986","article-title":"Neuropsychologia cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q11. 2 deletion syndrome","volume":"46","author":"Dufour","year":"2008","journal-title":"Schizophrenia"},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib57","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/302343","article-title":"Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome","volume":"64","author":"Edelmann","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn940","article-title":"Protein palmitoylation: a regulator of neuronal development and function","volume":"3","author":"el-Husseini Ael","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.ajp.158.3.447","article-title":"Velocardiofacial syndrome; are structural changes in the temporal and mesial temporal regions related to schizophrenia?","volume":"158","author":"Eliez","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(00)01005-2","article-title":"A\u00a0quantitative MRI study of posterior fossa development in velocardiofacial syndrome","volume":"49","author":"Eliez","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007870050005","article-title":"Young children with velo-cardio-facial syndrome (CATCH-22). Psychological and language phenotypes","volume":"9","author":"Eliez","year":"2000","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.schres.2007.11.040","article-title":"Neural bases of different cognitive strategies for facial affect processing in schizophrenia","volume":"100","author":"Fakra","year":"2008","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0006-3223(01)01231-8","article-title":"Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk","volume":"51","author":"Feinstein","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","article-title":"Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?","volume":"17","author":"Feinberg","year":"1982","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib65","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1073\/pnas.1101219108","article-title":"Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex","volume":"108","author":"Fenelon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10803-005-5036-9","article-title":"Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome","volume":"35","author":"Fine","year":"2005","journal-title":"J.\u00a0Autism Dev. Disord."},{"issue":"9","key":"10.1016\/j.neuropharm.2012.09.012_bib67","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.biopsych.2008.05.032","article-title":"Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals","volume":"64","author":"Fornito","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35053072","article-title":"Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration","volume":"409","author":"Fournier","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib69","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/S0033291700035601","article-title":"Exploring \u2018theory of mind\u2019 in people with schizophrenia","volume":"26","author":"Frith","year":"1996","journal-title":"Psychol. Med."},{"issue":"10","key":"10.1016\/j.neuropharm.2012.09.012_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/13158","article-title":"Brain development during childhood and adolescence: a longitudinal MRI study","volume":"2","author":"Giedd","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.schres.2007.08.016","article-title":"Structural changes to the fusiform gyrus: a cerebral marker for social impairments in 22q11.2 deletion syndrome?","volume":"96","author":"Glaser","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib72","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.95.17.9991","article-title":"Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior","volume":"95","author":"Gogos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib73","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7777","article-title":"The gene encoding proline dehydrogenase modulates sensorimotor gating in mice","volume":"21","author":"Gogos","year":"1999","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neuropharm.2012.09.012_bib74","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1026773005303","article-title":"Hyperprolinaemia in patients with deletion (22)(q11.2) syndrome","volume":"23","author":"Goodman","year":"2000","journal-title":"J.\u00a0Inherit. Mentab. Dis."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib75","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/nn1572","article-title":"COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome","volume":"8","author":"Gothelf","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mrdd.20089","article-title":"The contribution of novel brain imaging techniques to understanding the neurobiology of mental retardation and developmental disabilities","volume":"11","author":"Gothelf","year":"2005","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/ajp.2007.164.4.663","article-title":"Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome","volume":"164","author":"Gothelf","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145706006699","article-title":"Association of the low-activity COMT 158Met\u00a0allele with ADHD and OCD in subjects with velocardiofacial syndrome","volume":"10","author":"Gothelf","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2012.09.012_bib79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2007.07.021","article-title":"Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study","volume":"96","author":"Gothelf","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2012.09.012_bib207","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2007.07.021","article-title":"Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study","volume":"96","author":"Gothelf","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ddrr.9","article-title":"Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome","volume":"14","author":"Gothelf","year":"2008","journal-title":"Dev. Disabil. Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpsychires.2010.07.008","article-title":"Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome","volume":"45","author":"Gothelf","year":"2011","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib82","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/schbul\/sbm145","article-title":"Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities","volume":"34","author":"Green","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib83","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/CHI.0b013e3181b76683","article-title":"Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome","volume":"48","author":"Green","year":"2009","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib84","first-page":"226","article-title":"Cognitive aging, executive function, and fractional anisotropy: a diffusion tensor MR imaging study","volume":"28","author":"Grieve","year":"2007","journal-title":"AJNR Am. J. Neuroradiol"},{"issue":"7","key":"10.1016\/j.neuropharm.2012.09.012_bib85","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/1541-7786.MCR-10-0200","article-title":"A\u00a0sensitized RNA interference screen identifies a novel role for the PI3K p110\u03b3 isoform in medulloblastoma cell proliferation and chemoresistance","volume":"9","author":"Guerreiro","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib86","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1017\/S0033291700026398","article-title":"Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia","volume":"23","author":"Hafner","year":"1993","journal-title":"Psychol. Med."},{"issue":"22","key":"10.1016\/j.neuropharm.2012.09.012_bib87","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1016\/S0021-9258(19)70391-3","article-title":"The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain","volume":"255","author":"Hallcher","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"issue":"9","key":"10.1016\/j.neuropharm.2012.09.012_bib88","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1371\/journal.pone.0000873","article-title":"Brain expressed microRNAs implicated in schizophrenia etiology","volume":"2","author":"Hansen","year":"2007","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib89","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/sj.npp.1301543","article-title":"Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders","volume":"33","author":"Harrison","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib90","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-9861(19960603)369:3<331::AID-CNE1>3.0.CO;2-6","article-title":"Dendritic morphology and its effects on the amplitude and rise-time of synaptic signals in hippocampal CA3 pyramidal cells","volume":"344","author":"Henze","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib91","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0026-895X(25)09065-0","article-title":"L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons","volume":"41","author":"Henzi","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib92","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/107385840100700513","article-title":"Neural network models of schizophrenia","volume":"7","author":"Hoffman","year":"2001","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib93","first-page":"1","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies","volume":"169","author":"Howes","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-003-1627-3","article-title":"D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice","volume":"172","author":"Huotari","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib95","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/ajmg.b.31060","article-title":"Failure to confirm association between PIK4CA and psychosis in 22q11.2 deletion syndrome","volume":"153B","author":"Ikeda","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib96","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1176\/ajp.155.5.678","article-title":"Progressive reduction of temporal lobe structures in childhood-onset schizophrenia","volume":"155","author":"Jacobsen","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib97","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.mp.4001597","article-title":"Hyperprolinemia is a risk factor for schizoaffective disorder","volume":"10","author":"Jacquet","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib98","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/hmg\/11.19.2243","article-title":"PRODH mutations and hyperprolinemia in a subset of schizophrenic patients","volume":"11","author":"Jacquet","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib99","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ajcn\/52.2.307","article-title":"Plasma proline kinetics and concentrations in young men in response to dietary proline deprivation","volume":"52","author":"Jaksic","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopsych.2011.03.012","article-title":"Clinical and genetic high-risk paradigms: converging paths to psychosis meet in the temporal lobes","volume":"69","author":"Jalbrzikowski","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tics.2005.01.009","article-title":"Processes of change in brain and cognitive development","volume":"9","author":"Johnson","year":"2005","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib102","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ajmg.b.30605","article-title":"Is MYO9B the missing link between schizophrenia and celiac disease?","volume":"147","author":"Jungerius","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib103","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.b.30821","article-title":"Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese population","volume":"150B","author":"Kanahara","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbrainres.2004.09.029","article-title":"The molecular genetics of the 22q11-associated schizophrenia","volume":"132","author":"Karayiorgou","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib105","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1073\/pnas.92.17.7612","article-title":"Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11","volume":"92","author":"Karayiorgou","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1176\/appi.ajp.160.1.156","article-title":"Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia","volume":"160","author":"Kasai","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib107","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.biopsych.2010.10.027","article-title":"Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study","volume":"69","author":"Kates","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib108","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/088307380401900506","article-title":"Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2)","volume":"19","author":"Kates","year":"2004","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib109","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0006-3223(00)01002-7","article-title":"Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis","volume":"49","author":"Kates","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.chi.0000205704.33077.4a","article-title":"Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome)","volume":"45","author":"Kates","year":"2006","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.neuropharm.2012.09.012_bib112","doi-asserted-by":"crossref","first-page":"e1000252","DOI":"10.1371\/journal.pgen.1000252","article-title":"Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function","volume":"4","author":"Kempf","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib113","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1207\/s15324826an1304_7","article-title":"Social skills and executive function deficits in children with the 22q11 deletion syndrome","volume":"13","author":"Kiley-Brabeck","year":"2006","journal-title":"Appl. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib114","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/schbul\/sbn192","article-title":"Facial emotion perception in schizophrenia: a meta-analytic review","volume":"36","author":"Kohler","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib115","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archpsyc.65.7.746","article-title":"A\u00a0cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis","volume":"65","author":"Koo","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2012.09.012_bib116","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E","article-title":"Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity","volume":"88","author":"Kotler","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib117","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.155.4.509","article-title":"MRI study of cavum septi pellucidi in schizophrenia, affective disorder and schizotypal personality disorder","volume":"155","author":"Kwon","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib118","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1176\/ajp.155.6.835","article-title":"Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder","volume":"155","author":"Lachman","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib119","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.acn.2005.09.001","article-title":"The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology","volume":"21","author":"Lajiness-O'Neill","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/bjp.181.2.138","article-title":"Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms","volume":"181","author":"Lawrie","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30379","article-title":"Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome","volume":"144B","author":"Lewandowski","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib122","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/16.2.195","article-title":"Sexual dimorphism, brain morphology, and schizophrenia","volume":"16","author":"Lewine","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.09.012_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajmg.b.30049","article-title":"Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population","volume":"129B","author":"Li","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.09.012_bib125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000054858","article-title":"Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan","volume":"43","author":"Liou","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib126","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib127","doi-asserted-by":"crossref","first-page":"16859","DOI":"10.1073\/pnas.232186099","article-title":"Genetic variation in the 22q11 locus and susceptibility to schizophrenia","volume":"99","author":"Liu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib128","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.042700699","article-title":"Genetic variation at the 22q11 PRODH2\/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia","volume":"99","author":"Liu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2006.10.082","article-title":"Corpus callosum morphology and ventricular size in chromosome 22q11.2 deletion syndrome","volume":"1131","author":"Machado","year":"2007","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2012.09.012_bib130","doi-asserted-by":"crossref","first-page":"e25882","DOI":"10.1371\/journal.pone.0025882","article-title":"Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome","volume":"6","author":"Magn\u00e9e","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib131","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1073\/pnas.2235651100","article-title":"A\u00a0comprehensive analysis of 22q11 gene expression in the developing and adult brain","volume":"100","author":"Maynard","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"10.1016\/j.neuropharm.2012.09.012_bib132","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.psychres.2011.06.012","article-title":"Visual scanpath abnormalities in 22q11.2 deletion syndrome: is this a face specific deficit?","volume":"189","author":"McCabe","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00125817-200101000-00006","article-title":"Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!","volume":"3","author":"McDonald-McGinn","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib134","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archpsyc.57.7.637","article-title":"Schizophrenia as a disorder of developmentally reduced synaptic connectivity","volume":"57","author":"McGlashan","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib136","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biopsych.2010.09.039","article-title":"Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder","volume":"69","author":"Moreau","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib137","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3476(99)70415-4","article-title":"Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern [see comments]","volume":"134","author":"Moss","year":"1999","journal-title":"J.\u00a0Pediatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2012.09.012_bib138","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ng1375","article-title":"Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia","volume":"36","author":"Mukai","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib139","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nn.2204","article-title":"Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion","volume":"11","author":"Mukai","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","article-title":"High rates of schizophrenia in adults with velo-cardio-facial syndrome","volume":"56","author":"Murphy","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib141","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1176\/appi.ajp.158.2.244","article-title":"Three-dimensional mapping of gyral shape and cortical surface asymmetries in schizophrenia: gender effects","volume":"158","author":"Narr","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib142","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/nbdi.2002.0548","article-title":"A\u00a0twin study of genetic contributions to hippocampal morphology in schizophrenia","volume":"11","author":"Narr","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib143","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00125817-200101000-00017","article-title":"Neuropsychiatric disorders in the 22q11 deletion syndrome","volume":"3","author":"Niklasson","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib144","series-title":"Cavum Septi Pellucidi in Normals and Patients with Schizophrenia as Detected by Magnetic Resonance Imaging","author":"Nopoulos","year":"1997"},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/gm233","article-title":"Metabolome in schizophrenia and other psychotic disorders: a general population-based study","volume":"3","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Genome Med."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib146","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(03)12323-9","article-title":"Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison","volume":"361","author":"Pantelis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib147","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1073\/pnas.87.1.256","article-title":"The anterior cingulate cortex mediates processing selection in the stroop attentional conflict paradigm","volume":"87","author":"Pardo","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib148","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/nn1562","article-title":"Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice","volume":"8","author":"Paterlini","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib149","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","article-title":"Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits","volume":"147","author":"Penagarikano","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2012.09.012_bib150","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/gb-2007-8-2-r27","article-title":"microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder","volume":"8","author":"Perkins","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib151","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/13803390500434425","article-title":"Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia","volume":"28","author":"Pukrop","year":"2006","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib152","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/hmg\/ddl443","article-title":"Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome","volume":"16","author":"Raux","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib153","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","article-title":"Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study","volume":"167","author":"Reichenberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2012.09.012_bib154","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.b.10042","article-title":"Polymorphism screening of PIK4CA: possible candidate gene for chromosome 22q11-linked psychiatric disorders","volume":"116B","author":"Saito","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2012.09.012_bib156","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2009.09.016","article-title":"Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study","volume":"115","author":"Schaer","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib157","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02246671","article-title":"Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT","volume":"124","author":"Schlegel","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib158","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(99)00026-2","article-title":"Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging","volume":"40","author":"Schreiber","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib159","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tig.2009.10.004","article-title":"Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders","volume":"25","author":"Sebat","year":"2009","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archgenpsychiatry.2010.66","article-title":"Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis","volume":"67","author":"Seidman","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib161","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-3223(98)00281-9","article-title":"The reduced neuropil hypothesis: a circuit based model of schizophrenia","volume":"45","author":"Selemon","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib162","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.schres.2006.09.028","article-title":"Social cognition in schizophrenia: relationships with neurocognition and negative symptoms","volume":"90","author":"Sergi","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib163","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.neuroimage.2003.12.004","article-title":"Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome","volume":"21","author":"Shashi","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib164","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM199208273270905","article-title":"Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study","volume":"327","author":"Shenton","year":"1992","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib166","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nature08855","article-title":"Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia","volume":"464","author":"Sigurdsson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib167","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0010-9452(08)70889-X","article-title":"Visuospatial and numerical cognitive deficits in children with chromosome 22q11.2 deletion syndrome","volume":"41","author":"Simon","year":"2005","journal-title":"Cortex"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib168","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1017\/S0954579405050364","article-title":"A\u00a0multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children","volume":"17","author":"Simon","year":"2005","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib169","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuroimage.2004.11.018","article-title":"Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study","volume":"25","author":"Simon","year":"2005","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neuropharm.2012.09.012_bib170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1176\/appi.ajp.162.6.1090","article-title":"Lower prepulse inhibition in children with the 22q11 deletion syndrome","volume":"162","author":"Sobin","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2012.09.012_bib171","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.mp.4001609","article-title":"Associations between prepulse inhibition and executive visual attentin in children with the 22q11 deletin syndrome","volume":"10","author":"Sobin","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib172","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1542\/peds.2005-3114","article-title":"Olfactory disorder in children with 22q11 deletion syndrome","volume":"118","author":"Sobin","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib173","first-page":"587","article-title":"Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping","volume":"597","author":"Sowell","year":"1999","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib174","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1073858404263960","article-title":"Mapping changes in the human cortex throughout the span of life","volume":"10","author":"Sowell","year":"2004","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.138","article-title":"Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model","volume":"40","author":"Stark","year":"2008","journal-title":"Nat. Genet."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2012.09.012_bib208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2009.12.011","article-title":"Attenuated positivesymptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome","volume":"118","author":"Stoddard","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib176","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.biopsych.2010.05.034","article-title":"Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis","volume":"68","author":"Stone","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib177","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11689-010-9043-6","article-title":"White matter microstructure in 22q11 deletion syndrome: a pilot diffusion tensor imaging and voxel-based morphometry study of children and adolescents","volume":"2","author":"Sundram","year":"2010","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib178","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jmg.34.6.453","article-title":"Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS","volume":"34","author":"Swillen","year":"1997","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib179","first-page":"79","article-title":"The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence","volume":"10","author":"Swillen","year":"1999","journal-title":"Genet. Couns."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archgenpsychiatry.2009.12","article-title":"Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis","volume":"66","author":"Takahashi","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib181","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.biopsych.2009.07.027","article-title":"The role of DNA copy number variation in schizophrenia","volume":"66","author":"Tam","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib182","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2009.09.010","article-title":"Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome)","volume":"115","author":"Tan","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib183","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tins.2006.01.007","article-title":"Mapping brain maturation","volume":"29","author":"Toga","year":"2006","journal-title":"Trends Neurosci."},{"issue":"October","key":"10.1016\/j.neuropharm.2012.09.012_bib184","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2010_97","article-title":"Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders","volume":"119","author":"Tunbridge","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib185","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.61.11.1085","article-title":"Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study","volume":"61","author":"van Amelsvoort","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib186","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1192\/bjp.178.5.412","article-title":"Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome","volume":"178","author":"van Amelsvoort","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib187","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/archpsyc.61.4.346","article-title":"Hippocampal volumes in schizophrenic twins","volume":"61","author":"van Erp","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib188","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/01.chi.0000228131.56956.c1","article-title":"The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms","volume":"45","author":"Vorstman","year":"2006","journal-title":"J.\u00a0Am. Acad. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib189","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajmg.b.30827","article-title":"Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome","volume":"150B","author":"Vorstman","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.09.012_bib190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2008.132","article-title":"Proline affects brain function in 22q11DS children with the low activity COMT158 allele","volume":"34","author":"Vorstman","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib191","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1155174","article-title":"Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia","volume":"320","author":"Walsh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib192","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nature00867","article-title":"Oligodendrocyte-myelin glycoprotein is a nogo receptor ligand that inhibits neurite outgrowth","volume":"417","author":"Wang","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib193","first-page":"4431","article-title":"Proline utilization in Saccharomyces cerevisiae: sequence, regulation, and mitochondrial localization of the PUTI gene product","volume":"7","author":"Wang","year":"1987","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2012.09.012_bib209","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00041444-199912000-00003","article-title":"Lack of evidence for association between the COMT locus and schizophrenia","volume":"9","author":"Wei","year":"1999","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib194","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib195","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2005.08.028","article-title":"Neuropsychological performance over time in people at high risk of developing schizophrenia and controls","volume":"59","author":"Whyte","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"15","key":"10.1016\/j.neuropharm.2012.09.012_bib196","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1523\/JNEUROSCI.18-15-05594.1998","article-title":"An essential role for a small synaptic vesicle-associated phosphatidylinositol 4-kinase in neurotransmitter release","volume":"18","author":"Wiedemann","year":"1998","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.09.012_bib197","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajmg.b.20037","article-title":"Association between Val108\/158 met polymorphism of the COMT gene and schizophrenia","volume":"120B","author":"Wonodi","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2012.09.012_bib198","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00125817-200101000-00008","article-title":"Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion","volume":"3","author":"Woodin","year":"2001","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2012.09.012_bib199","first-page":"880","article-title":"Strong association of de novo copy number mutations with sporadic schizophrenia","volume":"40","author":"Xu","year":"2008","journal-title":"New York"},{"key":"10.1016\/j.neuropharm.2012.09.012_bib200","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1523\/JNEUROSCI.0665-07.2007","article-title":"Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum","volume":"27","author":"Yavich","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"February","key":"10.1016\/j.neuropharm.2012.09.012_bib201","first-page":"2","article-title":"The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome","author":"Zaleski","year":"2009","journal-title":"Eur. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:00:43Z","timestamp":1778634043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812004844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":202,"alternative-id":["S0028390812004844"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.09.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Converging levels of analysis on a genomic hotspot for psychosis: Insights from 22q11.2 Deletion Syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}